395
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Different Combinations of ALDH2 rs671, APOE rs429358, rs7412 Polymorphisms with Hypertension in Middle-Aged and Elderly People: A Case–Control Study

ORCID Icon, , , , &
Pages 915-927 | Received 23 Dec 2022, Accepted 27 Feb 2023, Published online: 11 Mar 2023

References

  • Turana Y, Tengkawan J, Chia YC. Hypertension and stroke in Asia: a comprehensive review from HOPE Asia. J Clin Hypertens. 2021;23(3):513–521. doi:10.1111/jch.14099
  • Ji E, Lee S. Antibody-based therapeutics for atherosclerosis and cardiovascular diseases. Int J Mol Sci. 2021;22(11):5770. doi:10.3390/ijms22115770
  • Liu C, Du L, Wang S, et al. Differences in the prevention and control of cardiovascular and cerebrovascular diseases. Pharmacol Res. 2021;170:105737. doi:10.1016/j.phrs.2021.105737
  • Buonacera A, Stancanelli B, Malatino L. Stroke and hypertension: an appraisal from pathophysiology to clinical practice. Curr Vasc Pharmacol. 2019;17(1):72–84. doi:10.2174/1570161115666171116151051
  • Poznyak AV, Sadykhov NK, Kartuesov AG, et al. Hypertension as a risk factor for atherosclerosis: cardiovascular risk assessment. Front Cardiovasc Med. 2022;9:959285. doi:10.3389/fcvm.2022.959285
  • Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: assessment, management, and challenges. Clin Cardiol. 2020;43(2):99–107. doi:10.1002/clc.23303
  • Naqvi S, Asar TO, Kumar V, et al. A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother. 2021;134:111156. doi:10.1016/j.biopha.2020.111156
  • Skipina TM, Soliman EZ, Upadhya B. Association between secondhand smoke exposure and hypertension: nearly as large as smoking. J Hypertens. 2020;38(10):1899–1908. doi:10.1097/HJH.0000000000002478
  • Nepali P, Suresh S, Pikale G, et al. Hypertension and the role of dietary fiber. Curr Probl Cardiol. 2022;47(7):101203. doi:10.1016/j.cpcardiol.2022.101203
  • Fujii R, Hishida A, Nakatochi M. Associations of genome-wide polygenic risk score and risk factors with hypertension in a Japanese population. Circ Genom Precis Med. 2022;15(4):e003612. doi:10.1161/CIRCGEN.121.003612
  • Miall WE, Oldham PD. The hereditary factor in arterial blood-pressure. Br Med J. 1963;1(5323):75–80. doi:10.1136/bmj.1.5323.75
  • Huebbe P, Rimbach G. Evolution of human apolipoprotein E (APOE) isoforms: gene structure, protein function and interaction with dietary factors. Ageing Res Rev. 2017;37:146–161. doi:10.1016/j.arr.2017.06.002
  • Regenhardt RW, Thon JM, Das AS, et al. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2020;77(10):1261–1269. doi:10.1001/jamaneurol.2020.1782
  • Khalil YA, Rabès JP, Boileau C, Varret M. APOE gene variants in primary dyslipidemia. Atherosclerosis. 2021;328:11–22. doi:10.1016/j.atherosclerosis.2021.05.007
  • Pereira LC, Nascimento JCR, Rêgo JMC, et al. Apolipoprotein E, periodontal disease and the risk for atherosclerosis: a review. Arch Oral Biol. 2019;98:204–212. doi:10.1016/j.archoralbio.2018.11.009
  • Yamazaki Y, Zhao N, Caulfield TR, Liu -C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501–518. doi:10.1038/s41582-019-0228-7
  • Forero DA, López-León S, González-Giraldo Y, et al. APOE gene and neuropsychiatric disorders and endophenotypes: a comprehensive review. Am J Med Genet B Neuropsychiatr Genet. 2018;177(2):126–142. doi:10.1002/ajmg.b.32516
  • Gao C, Fu X, Chu Q, Li J, Shu G. Relationship between the ApoE gene polymorphism and type 2 diabetes mellitus complications. Genet Test Mol Biomarkers. 2021;25(2):111–115. doi:10.1089/gtmb.2020.0130
  • Zhou T, Li H, Zhong H, Zhong Z, Lin S. Association of apoE gene polymorphisms with lipid metabolism in renal diseases. Afr Health Sci. 2020;20(3):1368–1381. doi:10.4314/ahs.v20i3.43
  • Sidaraite A, Vilkeviciute A, Glebauskiene B, Kriauciuniene L, Zaliuniene D, Liutkeviciene R. Association of ApoE haplotype with clinical evidence of pituitary adenoma. Gene. 2019;706:154–161. doi:10.1016/j.gene.2019.04.090
  • Abyadeh M, Heydarinejad F, Khakpash M, Asefi Y, Shab-Bidar S. Association of Apolipoprotein E gene polymorphism with Preeclampsia: a meta-analysis. Hypertens Pregnancy. 2020;39(2):196–202. doi:10.1080/10641955.2020.1753068
  • Seripa D, D’Onofrio G, Panza F, Cascavilla L, Masullo C, Pilotto A. The genetics of the human APOE polymorphism. Rejuvenation Res. 2011;14(5):491–500. doi:10.1089/rej.2011.1169
  • Liu Q, Wu H, Yu Z, Huang Q, Zhong Z. APOE gene ɛ4 allele (388C-526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population. J Clin Lab Anal. 2021;35(9):e23925. doi:10.1002/jcla.23925
  • Ahmed Laskar A, Younus H. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis. Drug Metab Rev. 2019;51(1):42–64. doi:10.1080/03602532.2018.1555587
  • Li K, Guo W, Li Z, et al. ALDH2 repression promotes lung tumor progression via accumulated acetaldehyde and DNA damage. Neoplasia. 2019;21(6):602–614. doi:10.1016/j.neo.2019.03.008
  • Tsai HY, Hsu YJ, Lu CY, et al. Pharmacological activation of aldehyde dehydrogenase 2 protects against heatstroke-induced acute lung injury by modulating oxidative stress and endothelial dysfunction. Front Immunol. 2021;12:740562. doi:10.3389/fimmu.2021.740562
  • Jiang WB, Zhao W, Chen H, et al. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clin Exp Pharmacol Physiol. 2018;45(3):303–311. doi:10.1111/1440-1681.12876
  • Sharma S, Patel F, Ara H, Bess E, Shum A, Bhattarai S. Rotenone-induced 4-HNE aggresome formation and degradation in HL-1 cardiomyocytes: role of autophagy flux. Int J Mol Sci. 2022;23(9):4675. doi:10.3390/ijms23094675
  • Zhang R, Liu B, Fan X, et al. Aldehyde dehydrogenase 2 protects against post-cardiac arrest myocardial dysfunction through a novel mechanism of suppressing mitochondrial reactive oxygen species production. Front Pharmacol. 2020;11:373. doi:10.3389/fphar.2020.00373
  • Opelt M, Eroglu E, Waldeck-Weiermair M, et al. Formation of nitric oxide by aldehyde dehydrogenase-2 is necessary and sufficient for vascular bioactivation of nitroglycerin. J Biol Chem. 2016;291(46):24076–24084. doi:10.1074/jbc.M116.752071
  • Xu T, Liu S, Ma T, Jia Z, Zhang Z, Wang A. Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension. Redox Biol. 2017;11:286–296. doi:10.1016/j.redox.2016.12.019
  • Rao H, Wu H, Yu Z, Huang Q. APOE genetic polymorphism rs7412 T/T genotype may be a risk factor for essential hypertension among Hakka people in Southern China. Int J Hypertens. 2022;2022:8145896. doi:10.1155/2022/8145896
  • Wu H, Huang Q, Yu Z, Zhong Z. Association of ALDH2 rs671 and MTHFR rs1801133 polymorphisms with hypertension among Hakka people in Southern China. BMC Cardiovasc Disord. 2022;22(1):128. doi:10.1186/s12872-022-02577-x
  • Zhang B, Hu M, Sun Y, Lin Y, Zhu C. Associations between the prevalence, treatment, control of hypertension and cognitive trajectories among Chinese middle-aged and older adults. Am J Geriatr Psychiatry. 2022;30(10):1123–1134. doi:10.1016/j.jagp.2022.03.005
  • James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520. doi:10.1001/jama.2013.284427
  • Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. doi:10.1016/j.jacc.2017.11.006
  • Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–212. doi:10.1038/s41569-018-0119-4
  • Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
  • Liu L, Chen CL, Lo K. Trends of status of hypertension in Southern China, 2012–2019. Int J Gen Med. 2020;13:599–608. doi:10.2147/IJGM.S267346
  • Li AL, Peng Q, Shao YQ, Fang X, Zhang YY. The interaction on hypertension between family history and diabetes and other risk factors. Sci Rep. 2021;11(1):4716. doi:10.1038/s41598-021-83589-z
  • Gupta-Malhotra M, Hashmi SS, Barratt MS, Milewicz DM, Shete S. Familial aggregation of first degree relatives of children with essential hypertension. Blood Press. 2018;27(5):289–296. doi:10.1080/08037051.2018.1463818
  • Singh M, Singh AK, Pandey P, Chandra S, Singh KA, Gambhir IS. Molecular genetics of essential hypertension. Clin Exp Hypertens. 2016;38(3):268–277. doi:10.3109/10641963.2015.1116543
  • Calvier L, Herz J, Hansmann G. Interplay of low-density lipoprotein receptors, LRPs, and lipoproteins in pulmonary hypertension. JACC Basic Transl Sci. 2022;7(2):164–180. doi:10.1016/j.jacbts.2021.09.011
  • Dankner R, Ben Avraham S, Harats D, Chetrit A. ApoE genotype, lipid profile, exercise, and the associations with cardiovascular morbidity and 18-year mortality. J Gerontol a Biol Sci Med Sci. 2020;75(10):1887–1893. doi:10.1093/gerona/glz232
  • Bhavani AB, Sastry KB, Reddy NK, Padma T. Lipid profile and apolipoprotein E polymorphism in essential hypertension. Indian Heart J. 2005;57(2):151–157.
  • Niu W, Qi Y, Qian Y, Gao P, Zhu D. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res. 2009;32(12):1060–1066. doi:10.1038/hr.2009.164
  • Stoumpos S, Hamodrakas SJ, Anthopoulos PG, Bagos PG. The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies including 13,940 cases and 16,364 controls. J Hum Hypertens. 2013;27(4):245–255. doi:10.1038/jhh.2012.37
  • Misra UK, Kalita J, Somarajan BI. Recurrent intracerebral hemorrhage in patients with hypertension is associated with APOE gene polymorphism: a preliminary study. J Stroke Cerebrovasc Dis. 2013;22(6):758–763. doi:10.1016/j.jstrokecerebrovasdis.2012.02.006
  • Zhang X, Zhao H, Zhang J, et al. Gene environment interaction of GALNT2 and APOE gene with hypertension in the Chinese Han Population. Biomed Mater Eng. 2015;26(Suppl 1):S1977–1983. doi:10.3233/BME-151501
  • de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke. 2004;35(5):1057–1060. doi:10.1161/01.STR.0000125859.71051.83
  • Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH, Lima-Costa MF. Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS). Braz J Med Biol Res. 2008;41(2):89–94. doi:10.1590/s0100-879x2008000200002
  • Léa Correa Leite M, Lima-Costa MF, Moriguchi EH. Age-related trends of blood pressure levels by apolipoprotein E genotype: the Bambuì Cohort Study of Ageing (1997–2008). Hypertens Res. 2013;36(3):270–276. doi:10.1038/hr.2012.175
  • Jia K, Wang H, Dong P. Aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism is associated with hypertension risk in Asians: a meta-analysis. Int J Clin Exp Med. 2015;8(7):10767–10772.
  • Mei XF, Hu SD, Liu PF, et al. ALDH2 gene rs671 polymorphism may decrease the risk of essential hypertension. Int Heart J. 2020;61(3):562–570. doi:10.1536/ihj.19-259
  • Ma C, Yu B, Zhang W, Wang W, Zhang L, Zeng Q. Associations between aldehyde dehydrogenase 2 (ALDH2) rs671 genetic polymorphisms, lifestyles and hypertension risk in Chinese Han people. Sci Rep. 2017;7(1):11136. doi:10.1038/s41598-017-11071-w
  • Hasi T, Hao L, Yang L, Su XL. Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study. Genet Mol Res. 2011;10(1):537–543. doi:10.4238/vol10-1gmr1056
  • Kim SS, Park S, Jin H-S. Interaction between ALDH2 rs671 and life habits affects the risk of hypertension in Koreans: a STROBE observational study. Medicine. 2021;100(28):e26664. doi:10.1097/MD.0000000000026664
  • Li ZM, Kong CY, Sun KY, Wang LS. The ALDH2 gene rs671 polymorphism is not associated with essential hypertension. Clin Exp Hypertens. 2017;39(8):691–695. doi:10.1080/10641963.2017.1299749
  • Ma XX, Zheng SZ, Shu Y, Wang Y, Chen XP. Association between carotid intima-media thickness and aldehyde dehydrogenase 2 glu504lys polymorphism in Chinese Han with essential hypertension. Chin Med J. 2016;129(12):1413–1418. doi:10.4103/0366-6999.183413
  • Shi D, Xie S, Li A, et al. APOE-ε4 modulates the association among plasma Aβ(42)/Aβ(40), vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults. Transl Psychiatry. 2022;12(1):128. doi:10.1038/s41398-022-01899-w
  • Pinheiro A, Demissie S, Scruton A, et al. Association of apolipoprotein E ɛ4 allele with enlarged perivascular spaces. Ann Neurol. 2022;92(1):23–31. doi:10.1002/ana.26364
  • Lahrach H, Essiarab F, Timinouni M, et al. Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis. Ren Fail. 2014;36(10):1504–1509. doi:10.3109/0886022X.2014.949760
  • Dybas J, Bulat K, Blat A, et al. Age-related and atherosclerosis-related erythropathy in ApoE/LDLR(-/-) mice. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165972. doi:10.1016/j.bbadis.2020.165972
  • Wei LK, Menon S, Griffiths LR, Gan SH. Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis. J Hum Hypertens. 2015;29(2):99–104. doi:10.1038/jhh.2014.53
  • Kalyuzhnaya OV, Bairova TA, Kolesnikova LI. Gene-gene interactions of apolipoprotein gene polymorphic variants in adolescents with essential arterial hypertension and dyslipidemia. Bull Exp Biol Med. 2017;163(4):456–460. doi:10.1007/s10517-017-3827-6